News

Article

PCI Acquires Biotec

PCI's acquisition of Biotech Services International expands the packaging services provider's presence in Europe.

PCI, a provider of packaging services, has acquired Biotec Services International, a provider of clinical trial services and temperature controlled pharmaceutical services headquartered in Bridgend, Wales, UK.  The addition expands PCI’s presence in the United Kingdom/European Union to support global investigational studies of medicinal products by adding packaging, storage, and distribution capacity, and consultative services for clinical trial supplies, the company reports.

Biotec supports global projects across a range of temperature conditions including controlled room temperature. A Recent facilities expansion quadrupled the company’s capacity to store, package and ship cold chain products, and includes a second purpose-built facility for the storage of advanced therapeutic medicinal products including include gene therapies, somatic cell therapies (stem cells) and tissue engineered products.

In August, PCI acquired Penn Pharma, adding pharmaceutical development and contained manufacturing services to its portfolio of clinical trial services, commercial packaging, and laboratory services. 

Source: PCI

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content